ADRO


Biotech Updates: Analysts Bullish on Relypsa Inc (RLYP) and Aduro BioTech Inc (ADRO)

Healthcare analysts provide insight into Relypsa Inc (NASDAQ:RLYP) and Aduro BioTech Inc (NASDAQ:ADRO) as Relypsa begins commercialization of Veltassa, a drug to treat hyperkalemia, …

Gap Between Aduro BioTech Inc & Advaxis, Inc. Widened After IPO Date (ADRO) (ADXS)

Aduro BioTech Inc’s (NASDAQ:ADRO) long awaited public debut has arrived. As expected, the hype for immunotherapies spilled over to Aduro as the company …

Aduro Bio Tech Inc is the Latest and Hottest Oncology IPO (ADRO)

Aduro Bio Tech Inc (NASDAQ:ADRO) begins trading on Wednesday morning at 10:25 ET having completed a $119 million IPO that values the immunotherapy …